Müller-Schweinitzer E
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):690-704.
Changes in tension of spiral strips from canine and human veins induced by various drugs are compared with results from the literature on human veins. The order of potencies of alpha-adrenoceptor stimulating amines (adrenaline greater than noradrenaline greater than dopamine greater than isoprenaline) is similar in human and canine veins. Comparison of the affinities for alpha-adrenoceptors of pharmacologic drugs (thymoxamine, indoramine, clonidine, dihydroergotamine) suggest marked differences between the alpha-adrenoceptors in veins from man and dog. Venoconstriction mediating 5-HT receptors and a very small population of beta-adrenoceptors exist in both species. Human veins are always dilated by histamine, while canine femoral veins in vitro are relaxed by lower and contracted by higher histamine concentrations. Prostaglandin F2 alpha constricts both canine femoral and human hand veins. PGA2 and PGE2 increase the tension of canine and human veins in vitro but dilate human hand veins in situ. The order of potencies of ergot alkaloids in canine femoral veins is ergotamine greater than dihydroergovaline greater than dihydroergotamine = dihydroergostine greater than methysergide, whereas in human hand veins it is ergotamine = dihydroergovaline greater than methysergide greater than dihydroergotamine greater than dihydroergostine. In dogs the venoconstrictor effect of ergotamine is mediated by at least 3 mechanisms: stimulation of [1] alpha-adrenoceptors, [2] 5-HT receptors and [3] endogenous prostaglandin synthesis. Stimulation of alpha-adrenoceptors by dihydroergotamine and of 5-HT receptors by ergotamine was confirmed on human hand veins in situ. Prejunctional receptors at sympathetic nerve terminals are involved in the regulation of venous tone. Inhibitory alpha-adrenoceptors, dopamine and PGE2 receptors as well as facilitating beta-adrenoceptor existing at human vasoconstrictor nerves may be stimulated or blocked by pharmacologic drugs thereby modifying venous tone.
将各种药物引起的犬类和人类静脉螺旋条带张力变化与关于人类静脉的文献结果进行比较。α-肾上腺素能受体激动胺(肾上腺素>去甲肾上腺素>多巴胺>异丙肾上腺素)的效力顺序在人类和犬类静脉中相似。对药理药物(噻吗洛尔、吲哚拉明、可乐定、双氢麦角胺)与α-肾上腺素能受体亲和力的比较表明,人类和犬类静脉中的α-肾上腺素能受体存在显著差异。两种物种均存在介导5-羟色胺受体的静脉收缩作用以及极少量的β-肾上腺素能受体。组胺总是使人类静脉扩张,而犬类股静脉在体外对低浓度组胺松弛,对高浓度组胺收缩。前列腺素F2α使犬类股静脉和人类手部静脉均收缩。前列腺素A2和前列腺素E2在体外增加犬类和人类静脉的张力,但在原位使人类手部静脉扩张。麦角生物碱在犬类股静脉中的效力顺序为麦角胺>双氢麦角缬碱>双氢麦角胺 = 双氢麦角甾醇>甲基麦角新碱,而在人类手部静脉中为麦角胺 = 双氢麦角缬碱>甲基麦角新碱>双氢麦角胺>双氢麦角甾醇。在犬类中,麦角胺的静脉收缩作用至少由3种机制介导:[1]刺激α-肾上腺素能受体,[2]刺激5-羟色胺受体,[3]刺激内源性前列腺素合成。在人类手部静脉原位证实了双氢麦角胺对α-肾上腺素能受体的刺激以及麦角胺对5-羟色胺受体的刺激。交感神经末梢的突触前受体参与静脉张力的调节。存在于人类血管收缩神经的抑制性α-肾上腺素能受体、多巴胺和前列腺素E2受体以及易化性β-肾上腺素能受体可被药理药物刺激或阻断,从而改变静脉张力。